Form 13-F position report

CORBUS PHARMACEUTICALS HLDG

Reported by Sculptor Capital LP

CRBP CUSIP 21833P103 Manager CIK 0001054587

Reported 0 shares, down 139,900 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2019
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 6 Through Q4 2019

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for CORBUS PHARMACEUTICALS HLDG held by Sculptor Capital LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

106 managers reported CORBUS PHARMACEUTICALS HLDG for Q4 2019.

Managers reporting CORBUS PHARMACEUTICALS HLDG in Q4 2019.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ETF MANAGERS GROUP LLC Reduced 5,779,642 -1,109,718 1.1% $31,557,000 9 qtrs
BlackRock Inc Reduced 5,412,203 -5,341 < 0.01% $29,551,000 12 qtrs
Knoll Capital Management LLC Added 5,045,870 +60,000 20.34% $27,550,000 19 qtrs
VANGUARD GROUP INC Added 3,221,097 +79,796 < 0.01% $17,587,000 19 qtrs
STATE STREET CORPORATION Added 1,121,673 +22,166 < 0.01% $6,124,000 14 qtrs
FMR LLC Unchanged 952,867 0 < 0.01% $5,203,000 13 qtrs
MORGAN STANLEY Reduced 785,838 -118,749 < 0.01% $4,290,000 19 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 779,955 +33,743 < 0.01% $4,258,000 18 qtrs
NORTHERN TRUST CORPORATION Added 695,751 +4,497 < 0.01% $3,799,000 19 qtrs
D E Shaw & Co Inc Reduced 675,153 -63,957 < 0.01% $3,686,000 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2019
Filed
February 14, 2020
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.